Margaux Lafaurie

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Venues

British journal of haematology

American journal of hematology

British journal of clinical pharmacology

Blood advances

Centre Régional de Pharmacovigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, CHU de Toulouse

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centre Régional de Pharmacovigilance, de Pharmacoépidémiologie et d'Informations sur le Médicament, CHU de Toulouse Nov 02 2018

France

Assistante spécialiste, Doctorante

Publications

Yoann Zadro, Margaux Lafaurie, Marc Michel, Maryse Lapeyre Mestre, Guillaume Moulis
Risk of hospitalization with infection in adults with primary AIHA treated with rituximab: a French nationwide study. Blood advances (2024)
Dennis Lund Hansen, Julien Maquet, Margaux Lafaurie, Sören Möller, Sigbjørn Berentsen, Henrik Frederiksen, Guillaume Moulis, David Gaist
Primary autoimmune haemolytic anaemia is associated with increased risk of ischaemic stroke: A binational cohort study from Denmark and France. British journal of haematology (2023)
Dennis Lund Hansen, Julien Maquet, Margaux Lafaurie, Sören Möller, Sigbjørn Berentsen, Henrik Frederiksen, Guillaume Moulis, David Gaist
Primary autoimmune haemolytic anaemia is associated with increased risk of ischaemic stroke: A binational cohort study from Denmark and France. British journal of haematology 204 (3) (2023)
Julien Maquet, Margaux Lafaurie, Marc Michel, Maryse Lapeyre Mestre, Guillaume Moulis
Drug-Induced Immune Hemolytic Anemia: Detection of New Signals and Risk Assessment in a Nationwide Cohort Study. Blood advances (2023)
Dennis Lund Hansen, Julien Maquet, Margaux Lafaurie, Sören Möller, Sigbjørn Berentsen, Henrik Frederiksen, Guillaume Moulis, David Gaist
Primary autoimmune haemolytic anaemia is associated with increased risk of ischaemic stroke: A binational cohort study from Denmark and France. British journal of haematology 204 (3) (2023)
Ondine Walter, Pierre Cougoul, Julien Maquet, Pablo Bartolucci, Maryse Lapeyre Mestre, Margaux Lafaurie, Guillaume Moulis
Risk of vaso-occlusive episode after exposure to corticosteroids in patients with sickle cell disease. Blood 139 (26) (2022)
Yoann Zelmat, Cécile Conte, Pernelle Noize, Clémentine Vabre, Marie Pajiep, Margaux Lafaurie, Maryse Lapeyre Mestre, Fabien Despas
Incidence of heart failure following exposure to a protein kinase inhibitor, a French population-based study. British journal of clinical pharmacology (2022)
Margaux Lafaurie, Guillaume Martin-Blondel, Pierre Delobel, Nassim Kamar, Sandrine Charpentier, Agnès Sommet, Guillaume Moulis, null null
Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19. BMC pharmacology & toxicology 22 (1) (2021)
Guillaume Moulis, Johanne Germain, Manuela Rueter, Margaux Lafaurie, Myriam Aroichane, Thibault Comont, Matthieu Mahevas, Jean-François Viallard, Stéphane Chèze, Mikaël Ebbo, Sylvain Audia, Soraya Leclerc-Teffahi, Agnès Sommet, Odile Beyne-Rauzy, Marc Michel, Bertrand Godeau, Maryse Lapeyre-Mestre, null null
Eltrombopag in adult patients with immune thrombocytopenia in the real-world in France, including off-label use before 6 months of disease duration: The multicenter, prospective ELEXTRA study. American journal of hematology (2021)
Jean-Louis Montastruc, Margaux Lafaurie, Claire de Canecaude, Geneviève Durrieu, Agnès Sommet, François Montastruc, Haleh Bagheri
Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database. British journal of clinical pharmacology 87 (11) (2021)
Margaux Lafaurie, Julien Maquet, Bérangère Baricault, Charlotta Ekstrand, Christian F Christiansen, Marie Linder, Shahram Bahmanyar, Mette Nørgaard, Laurent Sailler, Maryse Lapeyre Mestre, Agnès Sommet, Guillaume Moulis
Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study. British journal of haematology 195 (3) (2021)
Ondine Walter, Julien Maquet, Helene Derumeaux, Guillaume Moulis, Margaux Lafaurie
Validation of Discharge Diagnosis of Sickle Cell Disease Vaso-Occlusive Episodes in the French Hospital Electronic Database. Clinical epidemiology 13 (2021)
Julien Maquet, Margaux Lafaurie, Ondine Walter, Laurent Sailler, Agnès Sommet, Maryse Lapeyre Mestre, Marc Michel, Guillaume Moulis
Epidemiology of autoimmune hemolytic anemia: A nationwide population-based study in France. American journal of hematology 96 (8) (2021)
Julien Maquet, Margaux Lafaurie, Laurent Sailler, Maryse Lapeyre Mestre, Guillaume Moulis
Correspondence on 'Risk of systemic lupus erythematosus after immune thrombocytopenia and autoimmune haemolytic anaemia: a nationwide French study'. Annals of the rheumatic diseases (2020)
Margaux Lafaurie, Bérangère Baricault, Vincent Soler, Myriam Cassagne, Laurent Sailler, Maryse Lapeyre-Mestre, Agnès Sommet, Guillaume Moulis
No increased risk of cataract in adult patients with primary immune thrombocytopenia treated with eltrombopag. A French nationwide nested case-control study. British journal of haematology 189 (4) (2020)
Julien Maquet, Margaux Lafaurie, Agnès Sommet, Guillaume Moulis
Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19. British journal of haematology 190 (5) (2020)
Margaux Lafaurie, Guillaume Martin-Blondel, Pierre Delobel, Sandrine Charpentier, Agnès Sommet, Guillaume Moulis
Outcome of patients hospitalized for COVID-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: results of the ACE-CoV study. Fundamental & clinical pharmacology 35 (1) (2020)
Margaux Lafaurie, Pascale Olivier, Charles Khouri, Marina Atzenhoffer, Kévin Bihan, Geneviève Durrieu, Jean-Louis Montastruc
Myocardial infarction and ischemic stroke with vasoconstrictors used as nasal decongestant for common cold: a French pharmacovigilance survey. European journal of clinical pharmacology 76 (4) (2019)

Margaux Lafaurie.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Margaux Lafaurie